ArticleThoracic cancer2023

Pyrotinib plus antiangiogenic agents for HER2-altered advanced non-small cell lung cancer: A retrospective real-world study.

Yaning Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.